Pathogenic Role of mTOR Signaling in Cardiometabolic Disease: Implications for Heart, Liver, and Kidney Dysfunction.

Physiol Res · 2025 · PMC12721827 · PMID 41406476

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Further testing of Nox4 and AKT inhibitors (downstream of mTOR) or AMPK and Sirt1 activators (which regulate mTOR) may be significant for regulating mTOR and treating certain symptoms of CMDs.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.